INTERNATIONAL PATENT: CHARITE - UNIVERSITATSMEDIZIN BERLIN FILES APPLICATION FOR "EFFECT OF INTRAVENOUS FERRIC CARBOXYMALTOSE ON EXERCISE CAPACITY IN SYMPTOMATIC PATIENTS WITH HEART FAILURE AND A PRESERVED EJECTION FRACTION WITH IRON DEFICIENCY WITH AND WITHOUT ANAEMIA"

GENEVA, Nov. 17 -- CHARITE - UNIVERSITATSMEDIZIN BERLIN (Chariteplatz 110117 Berlin) filed a patent application (PCT/EP2025/062561) for "EFFECT OF INTRAVENOUS FERRIC CARBOXYMALTOSE ON EXERCISE CAPACITY IN SYMPTOMATIC PATIENTS WITH HEART FAILURE AND A PRESERVED EJECTION FRACTION WITH IRON DEFICIENCY WITH AND WITHOUT ANAEMIA" on May 07, 2025. With publication no. WO/2025/233434, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ANKER, Stefan (Oberseestrasse 9113053 Berlin)

Abstract: The invention relates to an iron carbohydr...